These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 28474588

  • 41. Apnea of prematurity: theophylline v. caffeine.
    Harrison H.
    Alaska Med; 1992; 34(4):173-6. PubMed ID: 1288312
    [Abstract] [Full Text] [Related]

  • 42. Neurobehavioral Outcomes 11 Years After Neonatal Caffeine Therapy for Apnea of Prematurity.
    Mürner-Lavanchy IM, Doyle LW, Schmidt B, Roberts RS, Asztalos EV, Costantini L, Davis PG, Dewey D, D'Ilario J, Grunau RE, Moddemann D, Nelson H, Ohlsson A, Solimano A, Tin W, Anderson PJ, Caffeine for Apnea of Prematurity (CAP) Trial Group.
    Pediatrics; 2018 May; 141(5):. PubMed ID: 29643070
    [Abstract] [Full Text] [Related]

  • 43. [Caffeine citrate utilization for treatment of apnea in French neonatal units].
    Ducrocq S, Biran-Mucignat V, Lebas F, Baudon JJ, Gold F.
    Arch Pediatr; 2006 Oct; 13(10):1305-8. PubMed ID: 16872813
    [Abstract] [Full Text] [Related]

  • 44. Caffeine citrate in the NICU.
    Flood E.
    Neonatal Netw; 1989 Apr; 7(5):37-9. PubMed ID: 2704353
    [Abstract] [Full Text] [Related]

  • 45. Efficacy and Safety of Different Maintenance Doses of Caffeine Citrate for Treatment of Apnea in Premature Infants: A Systematic Review and Meta-Analysis.
    Chen J, Jin L, Chen X.
    Biomed Res Int; 2018 Apr; 2018():9061234. PubMed ID: 30671477
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Caffeine citrate: a review of its use in apnoea of prematurity.
    Comer AM, Perry CM, Figgitt DP.
    Paediatr Drugs; 2001 Apr; 3(1):61-79. PubMed ID: 11220405
    [Abstract] [Full Text] [Related]

  • 52. Sequelae of caffeine treatment in preterm infants with apnea.
    Gunn TR, Metrakos K, Riley P, Willis D, Aranda JV.
    J Pediatr; 1979 Jan; 94(1):106-9. PubMed ID: 363996
    [Abstract] [Full Text] [Related]

  • 53. Plasma beta-endorphin concentration and xanthine treatment in apnea of prematurity.
    Sankaran K, Hindmarsh KW, Tan L, Kalapurackal M.
    Clin Invest Med; 1993 Jun; 16(3):197-203. PubMed ID: 8365047
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Duration of Caffeine for Apnea of Prematurity-A Randomized Controlled Trial.
    Prakash R, Pournami F, Prabhakar J, Nandakumar A, Nair PMC, Jain N.
    Indian J Pediatr; 2021 Dec; 88(12):1174-1179. PubMed ID: 33625665
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Doxapram in the treatment of idiopathic apnea of prematurity unresponsive to aminophylline.
    Alpan G, Eyal F, Sagi E, Springer C, Patz D, Goder K.
    J Pediatr; 1984 Apr; 104(4):634-7. PubMed ID: 6707826
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.